Antiarrhythmic use from 1991 to 2007: Insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Heart Rhythm
- Vol. 7 (9) , 1171-1177
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systemsThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2006
- Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial FibrillationAmerican Heart Journal, 2005
- Maintenance of sinus rhythm in patients with atrial fibrillationJACC, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials1993
- Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillationThe American Journal of Cardiology, 1993
- Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: Observations on the role of trial design and implications of drug-related mortalityAmerican Heart Journal, 1992
- Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillationJACC, 1992
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989